DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Raison CL. et al
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
JAMA Psychiatry 2013;
70 (01) 31-41
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.